Select Medical Holdings
$ 15.07
-0.59%
03 Dec - close price
- Market Cap 1,868,518,000 USD
- Current Price $ 15.07
- High / Low $ 15.32 / 15.00
- Stock P/E 18.38
- Book Value 13.64
- EPS 0.82
- Next Earning Report 2026-02-19
- Dividend Per Share $0.38
- Dividend Yield 2.47 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.08 %
- 52 Week High 20.47
- 52 Week Low 11.54
About
Select Medical Holdings Corporation is a premier provider of specialized post-acute care in the United States, primarily focusing on critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Based in Mechanicsburg, Pennsylvania, the company operates a vast network designed to deliver high-quality, integrated care that enhances patient outcomes across diverse healthcare settings. With a strong emphasis on innovative practices and comprehensive rehabilitation services, Select Medical is positioned as a crucial player in the healthcare continuum, adeptly addressing the needs of patients recovering from severe illnesses and injuries.
Analyst Target Price
$18.40
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-07-31 | 2025-04-30 | 2025-02-20 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-22 | 2023-11-02 | 2023-07-19 | 2023-05-04 | 2023-02-23 |
| Reported EPS | 0.23 | 0.6 | 0.44 | 0.18 | 0.43 | 0.6 | 0.75 | 0.36 | 0.46 | 0.61 | 0.56 | 0.22 |
| Estimated EPS | 0.1561 | 0.24 | 0.367 | 0.2449 | 0.43 | 0.61 | 0.57 | 0.36 | 0.41 | 0.48 | 0.44 | 0.36 |
| Surprise | 0.0739 | 0.36 | 0.073 | -0.0649 | 0 | -0.01 | 0.18 | 0 | 0.05 | 0.13 | 0.12 | -0.14 |
| Surprise Percentage | 47.3414% | 150% | 19.891% | -26.5006% | 0% | -1.6393% | 31.5789% | 0% | 12.1951% | 27.0833% | 27.2727% | -38.8889% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-19 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.234 |
| Currency | USD |
Previous Dividend Records
| Nov 2025 | Aug 2025 | May 2025 | Mar 2025 | Jan 1970 | Nov 2024 | Aug 2024 | May 2024 | Mar 2024 | Nov 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-11-25 | 2025-08-28 | 2025-05-29 | 2025-03-13 | None | 2024-11-26 | 2024-08-30 | 2024-05-30 | 2024-03-13 | 2023-11-28 |
| Amount | $0.0625 | $0.0625 | $0.0625 | $0.0625 | $17.85826823 | $0.125 | $0.125 | $0.125 | $0.125 | $0.125 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SEM
2025-10-16 11:52:09
Select Medical Holdings (NYSE:SEM) shareholders have experienced a 25% loss over the past year, despite an 11% increase in share price in the last month. The company's stock has underperformed the market significantly, with a 60% decline over the last year. While the company moved from a loss to a profit and saw a 29% revenue increase, market sentiment and other factors might be influencing the stock's performance.
2025-10-14 16:00:04
Select Medical (SEM) has been upgraded to a Zacks Rank #2 (Buy), driven by an upward trend in earnings estimates. This upgrade signifies an improving earnings outlook for the company, which is a powerful factor in influencing stock prices. The Zacks rating system highlights companies with strong earnings estimate revisions, aiming to identify stocks with potential for market-beating returns.
2025-10-14 15:23:43
Wall Street analysts predict a significant 36.47% upside for Select Medical (SEM), with a mean price target of $18. This optimism is supported by a positive trend in earnings estimate revisions and the company's Zacks Rank #2 (Buy). Investors are advised to consider price targets with skepticism but acknowledge the agreement among analysts and positive earnings outlook.
2025-10-14 13:55:02
Select Medical (SEM) shares recently gained 7.8% but Wall Street analysts predict a potential upside of 36.5% with a mean estimate of $18. This optimism is fueled by a positive trend in earnings estimate revisions and a Zacks Rank #2 (Buy), indicating good near-term potential, despite caveats about relying solely on price targets.
2025-10-14 13:40:09
Select Medical Holdings (SEM) saw a 10.2% stock increase following the Centers for Medicare & Medicaid Services (CMS) decision to delay a new rule, which is seen as favorable for post-acute care providers. This regulatory pause is expected to provide a one-time benefit in Q3 2025, offering some relief from prior financial challenges. The article discusses how this delay impacts Select Medical's investment outlook and its ability to manage ongoing regulatory risks related to Medicare reimbursement rates.
2025-10-14 13:40:02
This article evaluates Select Medical (SEM) as a potentially undervalued stock based on Zacks' ranking system and valuation metrics. SEM currently holds a Zacks Rank #2 (Buy) and a Value Grade of A, with attractive P/E, PEG, P/B, and P/CF ratios compared to its industry averages. These indicators suggest that SEM could be an impressive value stock given its earnings outlook.
